ISCHEMIA-CKD EXTEND is the long-term follow-up of surviving participants (projected median of 9 years) from the ISCHEMIA-CKD trial, a companion trial that ...

4 окт. 2022 г. · ISCHEMIA-CKD EXTEND is the long-term follow-up of surviving participants (projected median of 9 years) from the ISCHEMIA-CKD trial, a companion ...

29 авг. 2022 г. · Panagiotis Xaplanteris reports on the ISCHEMIA-CKD EXTEND trial results presented during the ESC 2022 congress in Barcelona.

ISCHEMIA-CKD EXTEND is the long-term follow-up of surviving participants (projected median of 9 years) from the ISCHEMIA-CKD trial, a companion trial that ...

6 сент. 2022 г. · The ISCHEMIA-CKD trial failed to show that routine invasive therapy was associated with a reduction in death/myocardial infarction vs. medical therapy.

ISCHEMIA-EXTEND is the long-term follow-up of randomized, surviving participants in the ISCHEMIA and ISCHEMIA-CKD trials. ISCHEMIA-EXTEND assesses whether an ...

Purpose: To assesses whether an initial invasive strategy —cardiac catheterization and revascularization when feasible plus optimal medical therapy (OMT) — ...

Продолжительность: 3:28
Опубликовано: 29 авг. 2022 г.

21 апр. 2023 г. · The aim of the ISCHEMIA trial was to determine whether routine cardiac catheterization and revascularization in patients with chronic coronary ... Abstract · Introduction · What should be the primary...

The Ischemia-CKD Extend Trial is the long term follow-up of the Ischemia-CKD Trial. The Ischemia-CKD Trial, in the randomized phase, we ask the question: in ...